Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.88

€7.88

1.490%
0.12
1.490%
€13.75
 
27.06.25 / Tradegate WKN: A1180P / Symbol: OCUL / Name: Ocular / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Ocular Therapeutix Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Ocular

sharewise wants to provide you with the best news and tools for Ocular, so we directly link to the best financial data sources.

News

Ocular Therapeutix Stock: Executive Sales Amidst Clinical Progress
Ocular Therapeutix Stock: Executive Sales Amidst Clinical Progress

Ocular Therapeutix, Inc. (NASDAQ: OCUL), the biotechnology firm with a market capitalization of $1.06 billion, recently reported several stock transactions by its leadership team. CEO Pravin Dugel

Why Ocular Therapeutix Was Bumping Higher This Week
Why Ocular Therapeutix Was Bumping Higher This Week

The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's stock higher.

As of Friday morning before market open, the eye care